Iqvia Holdings Inc.IQV
What Iqvia Holdings Inc. does.
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI ® , advanced analytics, the latest technologies and extensive domain expertise. We are committed to using artificial intelligence ("AI") responsibly, with AI-powered capabilities built on best-in-class approaches to privacy, regulatory compliance and patient safety, and delivering AI to the high standards of trust, scalability and precision demanded by the industry. With approximately 93,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, we are dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.
We are a global leader in protecting individual patient privacy. We use a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. Our insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $11.4B | $13.9B | $14.4B | $15.0B | $15.4B | $16.3B |
| Net income | $279.0M | $966.0M | $1.1B | $1.4B | $1.4B | $1.4B |
| Free cash flow | $1.3B | $2.3B | $1.6B | $1.5B | $2.1B | $2.1B |
More on IQV.
- Iqvia Holdings Inc. summary
- Iqvia Holdings Inc. financial statements
- Iqvia Holdings Inc. key metrics
- Iqvia Holdings Inc. health scores and style box
- Iqvia Holdings Inc. earnings
- Iqvia Holdings Inc. dividends
- Iqvia Holdings Inc. valuation
- Iqvia Holdings Inc. ownership and insiders
- Iqvia Holdings Inc. peers
Figures from Iqvia Holdings Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.